SurGenTec, a medical device company focused on advancing treatment options for orthopaedic and spine surgery, announced FDA clearance of its ION-L Lumbar Facet Fixation System. ION-L, part of SurGenTec's facet fixation platform, is indicated for the treatment of patients with degenerative disc disease (DDD) from L3 to S1 in skeletally mature patients who have failed conservative care. This clearance is supported by compelling long-term clinical evidence from an Institutional Review Board (IRB) approved multicenter study evaluating long-term surgical safety and efficacy.

ION-L was developed to address the demands of posterior lumbar facet fixation while minimising surgical footprint. Placed bilaterally through a posterior surgical approach, the system spans the facet joint interspace and is engineered for controlled, non-impact insertion to protect surrounding patient anatomy while reducing the need for extensive posterior exposure.

Key design features include:

Zero-profile implant design

Fenestrations and open barrels to support bone graft integration and fusion

Neutral joint positioning to reduce the risk of unintended joint expansion during insertion

Engagement features designed to resist implant expulsion

Nanotex surface technology with controlled pore sizes to attract and retain bone marrow aspirate and growth factors to support osseointegration

The ION-L clearance is supported by a multicenter clinical study conducted with IRB approval at all sites and conducted by an independent third-party organisation. Radiographic outcomes were independently reviewed by two radiologists to assess fusion outcomes and no adverse events were reported. The study evaluated a deliberately high-risk, real-world cohort —representing medically complex patients in whom durable lumbar fusion is hardest to achieve.

"ION-L reflects our continued commitment to building a comprehensive facet fixation platform that provides surgeons with consistent, reliable, and less invasive solutions across the spine," said Travis Greenhalgh, CEO and Founder of SurGenTec. "For decades, spinal fixation has relied on bulky hardware and invasive techniques. With ION-L, we have demonstrated that surgeons can achieve the same clinical goals through a less invasive, facet-based approach.”